BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
10 results:

  • 1. Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.
    Masunaga T; Tsukamoto S; Honoki K; Fujii H; Kido A; Akahane M; Tanaka Y; Mavrogenis AF; Errani C; Kawai A
    Jpn J Clin Oncol; 2023 Dec; 53(12):1153-1161. PubMed ID: 37814462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic Accuracy of Ultrasound in the diagnosis of Uterine Leiomyomas and sarcomas.
    Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
    J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
    Piao ZH; Zhou XC; Chen JY
    Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
    Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
    Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
    Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
    J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient.
    Zhou Z; McDade TP; Simons JP; Ng SC; Lambert LA; Whalen GF; Shah SA; Tseng JF
    Arch Surg; 2010 May; 145(5):426-31. PubMed ID: 20479339
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry.
    Ceschel S; Casotto V; Valsecchi MG; Tamaro P; Jankovic M; Hanau G; Fossati F; Pillon M; Rondelli R; Sandri A; Silvestri D; Haupt R; Cuttini M
    Pediatr Blood Cancer; 2006 Oct; 47(5):560-6. PubMed ID: 16395684
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Education, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study.
    Nagarajan R; Neglia JP; Clohisy DR; Yasui Y; Greenberg M; Hudson M; Zevon MA; Tersak JM; Ablin A; Robison LL
    Cancer; 2003 May; 97(10):2554-64. PubMed ID: 12733155
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Second cancers following pediatric Hodgkin's disease.
    Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
    J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington.
    Woods JS; Polissar L; Severson RK; Heuser LS; Kulander BG
    J Natl Cancer Inst; 1987 May; 78(5):899-910. PubMed ID: 3471999
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.